Review Article
Cell Therapy Augments Functional Recovery Subsequent to Spinal Cord Injury under Experimental Conditions
Table 1
Preclinical spinal cord injury trials using induced pluripotent stem cells (iPSCs)/embryonic stem cells (ESCs).
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mouse embryonic stem cells (mESCs); human embryonic stem cells (hESCs); human induced pluripotent stem cells (hiPSCs); neural progenitor cells (NPCs); Schwann cells (SCs); neurogenin 2 (Ngn2); motoneuron progenitor cells (MPCs); oligodendrocyte progenitor cells (OPCs); olfactory ensheathing cells (OECs). |